CraigEDevoeMDMHCM
Oncology • Lake Success, NYHematologic Oncology
Associate Professor, Medicine, Zucker School of Medicine at Hofstra/Northwell
Dr. Devoe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Lakeville Road
Zuckerberg Cancer Center
Lake Success, NY 11042Phone+1 516-734-8900Fax+1 516-734-7688
Education & Training
Harvard School of Public HealthMS, Masters of Health Care Management, 2015 - 2017
Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 2000 - 2003
NYU Grossman Long Island School of MedicineResidency, Internal Medicine, 1994 - 1997
Stony Brook University Health Sciences Center School of MedicineClass of 1994
Certifications & Licensure
NY State Medical License 1995 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer Start of enrollment: 2011 Apr 07
- PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14
- A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors Start of enrollment: 2023 Apr 14
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 1362 citationsAnti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trialCaroline Robert, Antoni Ribas, Jedd D. Wolchok, F. Stephen Hodi, Omid Hamid
Lancet. 2014-09-20 - 570 citationsOrganoid profiling identifies common responders to chemotherapy in pancreatic cancerHervé Tiriac, Pascal Belleau, Dannielle D. Engle, Dennis Plenker, Astrid Deschênes
Cancer Discovery. 2018-05-31 - 231 citationsPhase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer.Sunil R. Hingorani, William P. Harris, J. Thaddeus Beck, Boris A. Berdov, Stephanie Ann Wagner
Clinical Cancer Research. 2016-01-26
Press Mentions
COVID-19 Updates: WHO Reports 55% Jump in COVID-19 Cases Last WeekJanuary 12th, 2022- Why Breakthrough COVID Deaths Can Be MisunderstoodOctober 18th, 2021
Northwell to Recovered COVID-19 Patients: Donate Your PlasmaApril 13th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
